Dzeja P P, Vitkevicius K T, Redfield M M, Burnett J C, Terzic A
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA.
Circ Res. 1999 May 28;84(10):1137-43. doi: 10.1161/01.res.84.10.1137.
Although the downregulation of creatine kinase activity has been associated with heart failure, creatine kinase-deficient transgenic hearts have a preserved contractile function. This suggests the existence of alternative phosphotransfer pathways in the myocardium, the identity of which is still unknown. In this study, we examined the contribution of adenylate kinase-catalyzed phosphotransfer to myocardial energetics. In the isolated mitochondria/actomyosin system, which possesses endogenous adenylate kinase activity in both compartments, substrates for adenylate kinase promoted the rate and amplitude of actomyosin contraction that was further enhanced by purified adenylate kinase. Inhibition of adenylate kinase activity diminished both actomyosin contraction and mitochondrial respiration, which indicated reduced energy flow between mitochondria and myofibrils. In intact myocardium, the net adenylate kinase-catalyzed phosphotransfer rate was 10% of the total ATP turnover rate as measured by 18O-phosphoryl labeling in conjunction with gas chromatography and mass spectrometry. In pacing-induced failing heart, adenylate kinase-catalyzed phosphotransfer increased by 134% and contributed 21% to the total ATP turnover. Concomitantly, the contribution by creatine kinase dropped from 89% in normal hearts to 40% in failing hearts. These phosphotransfer changes were associated with reduced levels of metabolically active ATP but maintained overall ATP turnover rate. Thus, this study provides evidence that adenylate kinase facilitates the transfer of high-energy phosphoryls and signal communication between mitochondria and actomyosin in cardiac muscle, with an increased contribution to cellular phosphotransfer in heart failure. This phosphotransfer function renders adenylate kinase an important component for optimal myocardial bioenergetics and a compensatory mechanism in response to impaired intracellular energy flux in the failing heart.
尽管肌酸激酶活性下调与心力衰竭有关,但缺乏肌酸激酶的转基因心脏仍具有保留的收缩功能。这表明心肌中存在替代的磷酸转移途径,但其具体身份仍不清楚。在本研究中,我们研究了腺苷酸激酶催化的磷酸转移对心肌能量代谢的贡献。在分离的线粒体/肌动球蛋白系统中,两个区室均具有内源性腺苷酸激酶活性,腺苷酸激酶的底物促进了肌动球蛋白收缩的速率和幅度,纯化的腺苷酸激酶进一步增强了这种作用。抑制腺苷酸激酶活性会降低肌动球蛋白收缩和线粒体呼吸,这表明线粒体与肌原纤维之间的能量流动减少。在完整心肌中,通过18O-磷酸标记结合气相色谱和质谱法测量,腺苷酸激酶催化的净磷酸转移速率为总ATP周转率的10%。在起搏诱导的衰竭心脏中,腺苷酸激酶催化的磷酸转移增加了134%,占总ATP周转率的21%。与此同时,肌酸激酶的贡献从正常心脏中的89%降至衰竭心脏中的40%。这些磷酸转移变化与代谢活性ATP水平降低有关,但维持了总体ATP周转率。因此,本研究提供了证据,表明腺苷酸激酶促进了高能磷酸基团的转移以及心肌中线粒体与肌动球蛋白之间信号的传递,在心力衰竭中对细胞磷酸转移的贡献增加。这种磷酸转移功能使腺苷酸激酶成为最佳心肌生物能量学的重要组成部分,也是对衰竭心脏细胞内能量通量受损的一种代偿机制。